ArticleThe pharmacogenomics journal2019

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Federico Nichetti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.